Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

A glimpse into the future: recombinant proteins and small molecules for targeted therapies in rheumatic diseases.

Kalden JR, Braun J.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S168-70.

PMID:
19822067
2.

Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis.

Braun J, Kalden JR.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S164-7.

PMID:
19822066
3.

Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides.

Braun J, Baraliakos X, Brandt J, Sieper J.

Scand J Rheumatol. 2005 May-Jun;34(3):178-90. Review.

PMID:
16134723
4.

Anti-TNF therapy: what have we learned in 12 years?

Kalden JR.

Arthritis Res Ther. 2011 May 25;13 Suppl 1:S1. doi: 10.1186/1478-6354-13-S1-S1. No abstract available.

5.

Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.

Schett G, Coates LC, Ash ZR, Finzel S, Conaghan PG.

Arthritis Res Ther. 2011 May 25;13 Suppl 1:S4. doi: 10.1186/1478-6354-13-S1-S4. Review.

6.

Anti-tumor necrosis factor therapies reduce serum macrophage inflammatory protein-1alpha in ankylosing spondylitis.

Akbulut H, Koca SS, Ozgen M, Isik A.

J Rheumatol. 2010 May;37(5):1073-4. doi: 10.3899/jrheum.091469. No abstract available.

PMID:
20439531
7.

Management and treatment of ankylosing spondylitis.

Zochling J, Braun J.

Curr Opin Rheumatol. 2005 Jul;17(4):418-25. Review.

PMID:
15956838
8.

Advances in rheumatology: new targeted therapeutics.

Tak PP, Kalden JR.

Arthritis Res Ther. 2011 May 25;13 Suppl 1:S5. doi: 10.1186/1478-6354-13-S1-S5. Review.

9.

[Biological therapy of arthritis and systemic autoimmune diseases].

Tamási L, Szekanecz Z.

Orv Hetil. 2007 Apr 8;148 Suppl 1:63-70. Review. Hungarian.

PMID:
17430797
10.

Golimumab, the newest TNF-α blocker, comes of age.

Papagoras C, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):570-7. Epub 2015 Jan 20. Review.

PMID:
25602858
11.

[Rheumatology: Progress in Diagnosis and Treatments. Topics: III. Rheumatiod Arthritis and Allied Conditions; 1. Rheumatoid arthritis].

Kaneko Y.

Nihon Naika Gakkai Zasshi. 2014 Oct 10;103(10):2423-30. Review. Japanese. No abstract available.

PMID:
27514190
12.

[Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].

Lanfant-Weybel K, Lequerré T, Vittecoq O.

Presse Med. 2009 May;38(5):774-87. doi: 10.1016/j.lpm.2009.02.003. Epub 2009 Mar 26. French.

PMID:
19327945
13.

The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what's in it for African and Middle Eastern rheumatologists.

Alawadhi A, Alawneh K, Alzahrani ZA.

Clin Rheumatol. 2012 Sep;31(9):1281-7. doi: 10.1007/s10067-012-2040-2. Epub 2012 Aug 9. Review.

PMID:
22875700
14.

Therapy for ankylosing spondylitis: new treatment modalities.

Braun J, Breban M, Maksymowych WP.

Best Pract Res Clin Rheumatol. 2002 Sep;16(4):631-51. Review.

PMID:
12406431
15.

Biological therapies in the spondyloarthritides--the current state.

Braun J, Sieper J.

Rheumatology (Oxford). 2004 Sep;43(9):1072-84. Epub 2004 Jun 8. Review.

PMID:
15187239
16.

The "knowns" and "unknowns" of biologic therapy in ankylosing spondylitis.

Gensler L, Inman R, Deodhar A.

Am J Med Sci. 2012 May;343(5):360-3. doi: 10.1097/MAJ.0b013e318251406c. Review.

PMID:
22543538
17.
18.

Immunological therapies for rheumatoid arthritis.

Edwards CJ.

Br Med Bull. 2005 Sep 20;73-74:71-82. Print 2005. Review.

PMID:
16174791
19.

Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL.

Fafá BP, Louzada-Junior P, Titton DC, Zandonade E, Ranza R, Laurindo I, Peçanha P, Ranzolin A, Hayata AL, Duarte A, Silveira IG, Costa I, Macieira JC, Guedes-Barbosa LS, Bertolo MB, Sauma MF, Silva MB, Freire M, Scheinberg MA, Fernandes V, Bianchi W, Miranda JR, Pinheiro GR, Carvalho HM, Brenol CV, Pereira IA, de Castro GR, de Morais JC, Oliveira SK, de Abreu MM, Toledo RA, Pinheiro MM, Vieira WP, Valim V; BIOBADABRASIL.

Clin Rheumatol. 2015 May;34(5):921-7. doi: 10.1007/s10067-015-2929-7. Epub 2015 Apr 8.

PMID:
25851594
20.

[Biologics in the early treatment of ankylosing spondylitis and related forms of spondyloarthritis].

Langer HE.

Wien Med Wochenschr. 2008;158(7-8):200-5. doi: 10.1007/s10354-008-0522-2. Review. German.

PMID:
18500471

Supplemental Content

Support Center